Insider Selling: Integral Ad Science Holding Corp. (NASDAQ:IAS) CEO Sells 6,445 Shares of Stock

Integral Ad Science Holding Corp. (NASDAQ:IAS) CEO Lisa Utzschneider sold 6,445 shares of the company’s stock in a transaction that occurred on Monday, July 8th. The shares were sold at an average price of $9.68, for a total value of $62,387.60. Following the transaction, the chief executive officer now directly owns 214,563 shares of the company’s stock, valued at $2,076,969.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Lisa Utzschneider also recently made the following trade(s):

• On Monday, May 6th, Lisa Utzschneider sold 8,044 shares of Integral Ad Science stock. The shares were sold at an average price of $9.97, for a total value of $80,198.68.

Integral Ad Science Price Performance

NASDAQ IAS traded down $0.05 on Wednesday, reaching $9.60. 653,827 shares of the stock traded hands, compared to its average volume of 1,746,158. The firm’s fifty day simple moving average is $9.55 and its 200 day simple moving average is $11.50. The company has a quick ratio of 4.32, a current ratio of 4.32 and a debt-to-equity ratio of 0.13. The company has a market cap of $1.54 billion, a price-to-earnings ratio of 960.96, a P/E/G ratio of 1.69 and a beta of 1.53. Integral Ad Science Holding Corp. has a 12 month low of $7.98 and a 12 month high of $20.88.

Integral Ad Science (NASDAQ:IAS) last issued its quarterly earnings results on Thursday, May 9th. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.01). The firm had revenue of $114.50 million during the quarter, compared to analyst estimates of $112.12 million. Integral Ad Science had a return on equity of 0.32% and a net margin of 0.59%. The firm’s quarterly revenue was up 7.9% on a year-over-year basis. During the same period last year, the company posted $0.02 EPS. As a group, research analysts predict that Integral Ad Science Holding Corp. will post 0.22 EPS for the current fiscal year.

Institutional Investors Weigh In On Integral Ad Science

Several large investors have recently modified their holdings of IAS. Ameritas Investment Partners Inc. boosted its stake in shares of Integral Ad Science by 40.1% during the 1st quarter. Ameritas Investment Partners Inc. now owns 6,724 shares of the company’s stock worth $67,000 after acquiring an additional 1,924 shares in the last quarter. ProShare Advisors LLC purchased a new stake in shares of Integral Ad Science in the first quarter valued at $121,000. American Trust lifted its holdings in shares of Integral Ad Science by 18.0% in the first quarter. American Trust now owns 13,742 shares of the company’s stock valued at $137,000 after purchasing an additional 2,096 shares in the last quarter. Vontobel Holding Ltd. purchased a new stake in shares of Integral Ad Science in the fourth quarter valued at $176,000. Finally, Price T Rowe Associates Inc. MD raised its holdings in shares of Integral Ad Science by 55.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 19,215 shares of the company’s stock worth $192,000 after acquiring an additional 6,878 shares in the last quarter. 95.78% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on IAS shares. Raymond James lowered their target price on Integral Ad Science from $16.00 to $13.00 and set an “outperform” rating for the company in a report on Friday, May 10th. Morgan Stanley reaffirmed an “equal weight” rating and set a $12.00 target price (down from $18.00) on shares of Integral Ad Science in a report on Tuesday, April 16th. Craig Hallum decreased their price objective on Integral Ad Science from $20.00 to $18.00 and set a “buy” rating for the company in a report on Friday, May 10th. Loop Capital began coverage on Integral Ad Science in a report on Tuesday, April 30th. They issued a “buy” rating and a $15.00 price objective for the company. Finally, Barclays decreased their price objective on Integral Ad Science from $16.00 to $12.00 and set an “equal weight” rating for the company in a report on Monday, April 15th. Three research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $16.77.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.